According to Paradigm Biopharmaceuticals latest financial reports the total liabilities of PAR is $9.09M, an increase of 59.88% to 2022. At the end of 2022 company had $5.68M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Paradigm Biopharmaceuticals is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $9.09M | 59.88% |
2022 | $5.68M | 28.49% |
2021 | $4.42M | 55.88% |
2020 | $2.84M | 83.47% |
2019 | $1.55M | - |